[1]Nature,2017,vol.550,p.534-538
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
1172356-50-1
1440-62-6
144236-37-3
56414-96-1
24152-96-3
39890-46-5
384377-41-7 | 2-([(1-Butyl-1h-benzimidazol-2-yl)amino]methyl)phenol | AA00C5OT | MFCD02921086
40359-34-0 | Methyl (2-formylphenoxy)acetate | AA00C5U0 | MFCD02629604
42059-58-5 | (2E)-3-(4-oxo-4H-chromen-3-yl)prop-2-enoic acid | AA00C5Z1 | MFCD01548049
382-93-4 | Methyl 2,3,3,3-tetrafluoropropionate | AA00C67M | MFCD00041536
330600-85-6 | (1S,2S,3R,4R)-4-carbamimidamido-3-[(1S)-1-acetamido-2-ethylbutyl]-2-hydroxycyclopentane-1-carboxylic acid | AA00C6EE | MFCD09837902
3970-41-0 | 2-Chloro-3-nitroaniline | AA00C6I2 | MFCD00800473
40245-26-9 | Methyl quinoline-8-carboxylate | AA00C6M8 | MFCD06203774
327072-13-9 | 2-(2,5-Dimethylphenylsulfonamido)benzoic acid | AA00C6RC | MFCD02706677
34409-44-4 | Dichlorobis(di-tert-butylphenylphosphine)palladium(ii) | AA00C6WC | MFCD09953450
398151-25-2 | 3-(4-Formylphenyl)phenol | AA00C73L | MFCD04117376